{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:06:21Z","timestamp":1790820381798,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["101057604"],"award-info":[{"award-number":["101057604"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009252","name":"SciLifeLab","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011898","name":"Marianne and Marcus Wallenberg Foundation","doi-asserted-by":"publisher","award":["MMW2011.0115"],"award-info":[{"award-number":["MMW2011.0115"]}],"id":[{"id":"10.13039\/501100011898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["521-2013-2339"],"award-info":[{"award-number":["521-2013-2339"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["523-2014-2342"],"award-info":[{"award-number":["523-2014-2342"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["523-2014-07605"],"award-info":[{"award-number":["523-2014-07605"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2022-0098"],"award-info":[{"award-number":["FO2022-0098"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["2022\/446"],"award-info":[{"award-number":["2022\/446"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.psyneuen.2024.107009","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T05:59:57Z","timestamp":1709099997000},"page":"107009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Mid-pregnancy allopregnanolone levels and trajectories of perinatal depressive symptoms"],"prefix":"10.1016","volume":"164","author":[{"given":"Richelle D.","family":"Bj\u00f6rv\u00e4ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylva","family":"Walld\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Fransson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Comasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Sundstr\u00f6m-Poromaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkistis","family":"Skalkidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2024.107009_bib1","article-title":"Prevalence and correlates of perinatal depression","author":"Al-abri","year":"2023","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.psyneuen.2024.107009_bib2","series-title":"Diagnostic and statistical manual of mental disorders: DSM-5","year":"2013"},{"key":"10.1016\/j.psyneuen.2024.107009_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031514","article-title":"Cohort profile: the Biology, Affect, Stress, Imaging and Cognition (BASIC) study on perinatal depression in a population-based Swedish cohort","volume":"9","author":"Axfors","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.psyneuen.2024.107009_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/apha.12440","article-title":"Expression of GABA receptors subunits in peripheral blood mononuclear cells is gender dependent, altered in pregnancy and modified by mental health","volume":"213","author":"Bhandage","year":"2015","journal-title":"Acta Physiol."},{"key":"10.1016\/j.psyneuen.2024.107009_bib5","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00213-016-4217-x","article-title":"Blunted neuroactive steroid and HPA axis responses to stress are associated with reduced sleep quality and negative affect in pregnancy: a pilot study","volume":"233","author":"Crowley","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psyneuen.2024.107009_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.104827","article-title":"Longitudinal proneuroactive and neuroactive steroid profiles in medication-free women with, without and at-risk for perinatal depression: a liquid chromatography-tandem mass spectrometry analysis","volume":"121","author":"Deligiannidis","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2024.107009_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.psyneuen.2016.05.010","article-title":"Peripartum neuroactive steroid and \u03b3-aminobutyric acid profiles in women at-risk for postpartum depression","volume":"70","author":"Deligiannidis","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2024.107009_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.699740","article-title":"Brexanolone, a GABAA modulator, in the treatment of postpartum depression in adults: a comprehensive review","volume":"12","author":"Edinoff","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107009_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jad.2022.09.143","article-title":"Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program","volume":"320","author":"Epperson","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2024.107009_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40263-019-00605-7","article-title":"Pharmacotherapy of postpartum depression: current approaches and novel drug development","volume":"33","author":"Frieder","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psyneuen.2024.107009_bib11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/09513590500361747","article-title":"3alpha-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period","volume":"21","author":"Gilbert Evans","year":"2005","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.psyneuen.2024.107009_bib12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/GRF.0000000000000368","article-title":"Predictors of postpartum depression: a comprehensive review of the last decade of evidence","volume":"61","author":"Guintivano","year":"2018","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.psyneuen.2024.107009_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yhbeh.2017.06.008","article-title":"Allopregnanolone levels and depressive symptoms during pregnancy in relation to single nucleotide polymorphisms in the allopregnanolone synthesis pathway | Elsevier Enhanced Reader","volume":"94","author":"Hellgren","year":"2017","journal-title":"Horm. Behav."},{"key":"10.1016\/j.psyneuen.2024.107009_bib14","first-page":"147","article-title":"Low serum allopregnanolone is associated with symptoms of depression in late pregnancy","volume":"69","author":"Hellgren","year":"2014","journal-title":"NPS"},{"key":"10.1016\/j.psyneuen.2024.107009_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.biopsycho.2005.02.007","article-title":"Histories of depression, allopregnanolone responses to stress, and premenstrual symptoms in women","volume":"71","author":"Klatzkin","year":"2006","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.psyneuen.2024.107009_bib16","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1210\/jcem.85.7.6675","article-title":"Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients","volume":"85","author":"Luisi","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2024.107009_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuron.2008.06.019","article-title":"GABAAR plasticity during pregnancy: relevance to postpartum depression","volume":"59","author":"Maguire","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.psyneuen.2024.107009_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/09540261.2018.1553775","article-title":"Allopregnanolone and reproductive psychiatry: an overview","volume":"31","author":"McEvoy","year":"2019","journal-title":"Int Rev. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107009_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2020.100212","article-title":"Allopregnanolone in postpartum depression: role in pathophysiology and treatment","volume":"12","author":"Meltzer-Brody","year":"2020","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.psyneuen.2024.107009_bib20","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","article-title":"Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"392","author":"Meltzer-Brody","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.psyneuen.2024.107009_bib21","article-title":"Postpartum depression: current status and future directions","volume":"9","author":"O\u2019Hara","year":"2013","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.psyneuen.2024.107009_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2019.01033","article-title":"The role of allopregnanolone in pregnancy in predicting postpartum anxiety symptoms","volume":"10","author":"Osborne","year":"2019","journal-title":"Front. Psychol."},{"key":"10.1016\/j.psyneuen.2024.107009_bib23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.psyneuen.2017.02.012","article-title":"Lower allopregnanolone during pregnancy predicts postpartum depression: an exploratory study","volume":"79","author":"Osborne","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2024.107009_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.yfrne.2018.12.001","article-title":"Pathophysiological mechanisms implicated in postpartum depression","volume":"52","author":"Payne","year":"2019","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.psyneuen.2024.107009_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fgwh.2022.823616","article-title":"Allopregnanolone in postpartum depression","volume":"3","author":"Pinna","year":"2022","journal-title":"Front. Glob. Women\u2019S. Health"},{"key":"10.1016\/j.psyneuen.2024.107009_bib26","first-page":"157","article-title":"Brexanolone (Zulresso): finally, an FDA-approved treatment for postpartum depression","volume":"54","author":"Powell","year":"2020","journal-title":"Ann. Pharm."},{"key":"10.1016\/j.psyneuen.2024.107009_bib27","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3109\/08039488.2011.590606","article-title":"The Swedish validation of Edinburgh Postnatal Depression Scale (EPDS) during pregnancy","volume":"65","author":"Rubertsson","year":"2011","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.107009_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1017\/S1092852914000480","article-title":"The role of reproductive hormones in postpartum depression","volume":"20","author":"Schiller","year":"2015","journal-title":"CNS Spectr."},{"key":"10.1016\/j.psyneuen.2024.107009_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.479646","article-title":"Steroid hormone sensitivity in reproductive mood disorders: on the role of the GABAA receptor complex and stress during hormonal transitions","volume":"7","author":"Schweizer-Schubert","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.psyneuen.2024.107009_bib30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00737-021-01186-5","article-title":"Allopregnanolone and depression and anxiety symptoms across the peripartum: an exploratory study","volume":"25","author":"Standeven","year":"2022","journal-title":"Arch. Women\u2019s\u00a0Ment. Health"},{"key":"10.1016\/j.psyneuen.2024.107009_bib31","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00737-021-01186-5","article-title":"Allopregnanolone and depression and anxiety symptoms across the peripartum: an exploratory study","volume":"25","author":"Standeven","year":"2022","journal-title":"Arch. Women\u2019s\u00a0Ment. Health"},{"key":"10.1016\/j.psyneuen.2024.107009_bib32","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00737-016-0629-1","article-title":"A review of longitudinal studies on antenatal and postnatal depression","volume":"19","author":"Underwood","year":"2016","journal-title":"Arch. Women\u2019s. Ment. Health"},{"key":"10.1016\/j.psyneuen.2024.107009_bib33","unstructured":"US Food and Drug Administration, 2023. FDA Approves First Oral Treatment for Postpartum Depression [WWW Document]. FDA. URL \u3008https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-oral-treatment-postpartum-depression\u3009 (accessed 2.19.24)."},{"key":"10.1016\/j.psyneuen.2024.107009_bib34","first-page":"1","article-title":"mice: Multivariate Imputation by Chained Equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.psyneuen.2024.107009_bib35","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/jnr.24390","article-title":"Characteristics of women with different perinatal depression trajectories","volume":"98","author":"Wikman","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.psyneuen.2024.107009_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.psychres.2019.07.006","article-title":"Brexanolone for postpartum depression: a meta-analysis of randomized controlled studies","volume":"279","author":"Zheng","year":"2019","journal-title":"Psychiatry Res."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453024000532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453024000532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T17:20:59Z","timestamp":1759684859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453024000532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":36,"alternative-id":["S0306453024000532"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2024.107009","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mid-pregnancy allopregnanolone levels and trajectories of perinatal depressive symptoms","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2024.107009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107009"}}